Furuya Lab banner image
FURUYA LABORATORY
Precision cancer prevention & biomarker-driven early detection

We develop and validate non-invasive biomarkers and integrative multi-omics strategies to enable earlier detection, risk stratification, and precision treatment of cancer—with a major focus on bladder cancer and upper-tract urothelial carcinoma.

Urine biomarkers Multiplex protein assays Radiogenomics Spatial biology Clinical translation

Contact

General: info@furuyalab.org
PI: hideki@furuyalab.org

Affiliation: Cedars-Sinai Medical Center

Cedars-Sinai lab page
LinkedIn